Dublin, Oct. 05, 2021 (GLOBE NEWSWIRE) -- The "Whole Genome And Exome Sequencing Markets" report has been added to ResearchAndMarkets.com's offering.
Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What's holding the industry back? Where are the over 800 locations that have high throughput devices?
A plummeting of costs for Whole Genome Sequencing is creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well-funded players are racing for market share on a truly global stage. The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions.
Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
Market Participants Play Different Roles
Independent lab specialized/esoteric
Independent lab national/regional
Independent lab analytical
Public National/regional lab
Whole Genome Sequencing -Markets, Examples and Discussion
Direct to Consumer - Two Approaches
The New Age of Medical Information
Dangers in DTC-WGS - Health Costs and Regulation
Newborn and Prenatal - A Brave New World
DTC - How Many Segments?
Research Funding and Capital Expense
WGS Datasets Preferred
Existing research repurposed
Organism Wide Market
Service Suppliers Respond
Clinical - Understanding Germline and Somatic
Somatic - Chasing Mutations and Pharmacogenomics
The Hepatitis C Story
Will the Microbiology Department Disappear?
AgriBio - Big Business
GMO is Here to Stay
WGS Benefits and Risks
The New Agriculture
Hospital's Testing Share
Economies of Scale
Instrument Manufacturer Role
Healthcare Industry Impacts - Still Struggling
Can the Healthcare Industry Adapt?
Genetic Counselling as an Industry
WGES Adoption and Cannibalization
The Meaning of Grail
Factors Driving Growth
Interpreting the Code Otherwise
Changes in Agriculture.
Fertility Technology Comes of Age
Factors Limiting Growth
Increased Competition Lowers Price
Healthcare Cost Concerns Curtail Growth
Wellness has a downside
GMO Opposition Movement.
Declining Cost of Instruments Changes Industry Structure.
What is Oxford Nanopore Sequencing?
What can Oxford Nanopore Sequencing be used for?
Oxford Nanopore Products
Long Reads - Further Segmentation
Targeted Sequencing Adopts CRISPR
New Sequencing Technologies
WGES Recent Developments
UK Whole-Genome Sequencing Project Obtains £200M
WGS may help with disease outbreaks
Veritas Cuts WGS Price by 40%
Dante Labs Launches GenomeL, Long Reads Human Whole Genome Sequencing
Machine-learning system used to diagnose genetic diseases
Whole Genome Sequencing for healthy creates controversy
100,000 whole genomes sequenced in the NHS
Nebula Genomics Offers FREE Whole Genome Sequencing
Veritas Genetics has time limited WGS offer for $199
Veritas Genetics Launches Two New Whole Genome Sequencing Products
BGI unveils a powerful new sequencer
State of California Funds $2M Whole-Genome Sequencing Pilot
Rapid genome sequencing could revolutionize health care
Human Longevity Launches Whole Genome Product, MassMutual Partnerships
$1500 to sequence newborns in China
Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion
PerkinElmer Launches Clinical Whole Genome Sequencing Services
Nine Centres use Oxford Nanopore MinION to Sequence Human Genome
Esperite and BGI Genomics sign a strategic agreement to offer Whole Genome
Sequencing on a large scale
Easily Affordable Whole-genome Sequencing is Goal of Mayo Collaboration with Veritas
Regeneron Partners With AbbVie, Alnylam, AstraZeneca, Biogen, Pfizer to Sequence UK
MedGenome Expands Its NGS Capabilities and Forays Into Single-Cell Sequencing
Genomics England Adopts Edico's Dragen For NGS Analysis
BGI Says It Will Slash Cost of Gene Testing to $300
Position Statement Spells Out Fetal Diagnostic Sequencing Recommendations
Dante Labs Announces 10,000 European Genome Project
Profiles of Key Companies
10x Genomics, Inc
Admera Health, LLC
Agena Bioscience, Inc
Baylor Miraca Genetics Laboratories
Beckman Coulter, Inc
Becton, Dickinson and Company
BGI Genomics Co. Ltd
Bio-Rad Laboratories, Inc.
Caris Molecular Diagnostics
Complete Genomics, Inc. - A BGI Company
Datar Cancer Genetics Limited
FUJIFILM Wako Diagnostics
GE Global Research
GE Healthcare Life Sciences
Gene by Gene, Ltd
Genetron Health (Beijing) Co., Ltd.
Genomics Personalized Health (GPH)
HTG Molecular Diagnostics
Human Longevity, Inc
MDNA Life SCIENCES, Inc
Novogene Bioinformatics Technology Co., Ltd
Oxford Nanopore Technologies
Personal Genome Diagnostics
Roche Molecular Diagnostics
Singlera Genomics Inc
Sure Genomics, Inc
Tempus Labs, Inc
Thermo Fisher Scientific Inc
For more information about this report visit https://www.researchandmarkets.com/r/j5bjic
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900